TCL Archive Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival November 29, 2013Vol.36 No.11
TCL Archive Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response November 29, 2013Vol.36 No.11
TCL Archive Two Papers Evaluate CyberKnife Survival Rates and Tolerability November 29, 2013Vol.36 No.11
TCL Archive ANG1005 Demonstrates Activity In Patients with Brain Metastases November 29, 2013Vol.36 No.11
TCL Archive MM-121 Study Fails PFS Endpoint, Biomarker Analysis Continues November 29, 2013Vol.36 No.11
TCL Archive AGS-003 Immunotherapy Induces T Cell Responses in Phase II Trial November 29, 2013Vol.36 No.11
TCL Archive Building Boom of Proton Beam Centers Flares Up in Washington and Baltimore October 25, 2013Vol.39 No.40
TCL Archive Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival October 25, 2013Vol.36 No.10
